Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial Read More » August 12, 2024
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks Read More » July 25, 2024
Teva Pharmaceuticals and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease Read More » July 25, 2024
Enterprise Therapeutics Doses First Person with Cystic Fibrosis in Phase 2 Trial for Novel Therapy ETD001 Read More » July 23, 2024
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia Read More » July 22, 2024